Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.
about
Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progressionNovel small molecule inhibiting CDCP1-PKCδ pathway reduces tumor metastasis and proliferation.Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumorsCell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer.New crossroads for potential therapeutic intervention in cancer - intersections between CDCP1, EGFR family members and downstream signaling pathways.CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?CD318 is a ligand for CD6.CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.
P2860
Q28076686-E6042F1E-F89E-41B6-AFC9-5096CDCFD495Q33738983-9F0704F3-DAA2-42A7-9103-804F3372D17BQ36296805-FD26864B-313C-4F44-A15C-B91CD800D928Q36750564-47FA1D9B-67B2-46F8-A6C2-E8459A54C431Q37176588-CCFE35FE-9DD9-4F6A-A08C-159839569841Q37341866-DA884CF1-D944-4DD0-A905-40795AEC572CQ38388622-FE86ADA2-1CFE-4BDE-9A4A-3B7EE79C7B1EQ38771403-1F2FDD8D-2D7C-460F-8057-168AD59A9E84Q39218490-4420BD79-68A1-475C-8849-749FDE9983DCQ41476987-454B84CF-D2E7-42C7-A73E-B7569A3E8A4BQ42317491-6209C116-533E-43DF-AD03-6619C1E1276EQ46085514-E71A08DD-3AE0-4E73-A9F3-9131455C6969Q55248632-9F793C20-2D0A-49AB-AB59-7248B5189B09
P2860
Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Elevated CDCP1 predicts poor p ...... migration and chemoresistance.
@en
type
label
Elevated CDCP1 predicts poor p ...... migration and chemoresistance.
@en
prefLabel
Elevated CDCP1 predicts poor p ...... migration and chemoresistance.
@en
P2093
P2860
P50
P356
P1433
P1476
Elevated CDCP1 predicts poor p ...... migration and chemoresistance.
@en
P2093
A J Crandon
A V Tinker
B G Hollier
B S Harrington
B Winterhoff
C M Davies
C M Shannon
G E Konecny
P2860
P2888
P304
P356
10.1038/ONC.2015.101
P407
P577
2015-04-20T00:00:00Z
P5875
P6179
1050170603